Loading...
Sumitomo Chemical Company, Limited
SOMMF•PNK
Basic Materials
Chemicals
$2.75
$0.00(0.00%)
Sumitomo Chemical Company, Limited (SOMMF) Financial Performance & Income Statement Overview
Review Sumitomo Chemical Company, Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.51%
↑ 6.51%
Operating Income Growth
132.11%
↑ 132.11%
Net Income Growth
112.38%
↑ 112.38%
Operating Cash Flow Growth
554.09%
↑ 554.09%
Operating Margin
4.67%
↑ 4.67%
Gross Margin
27.84%
↑ 27.84%
Net Profit Margin
1.48%
↑ 1.48%
ROE
4.08%
↑ 4.08%
ROIC
5.07%
↑ 5.07%
Sumitomo Chemical Company, Limited (SOMMF) Income Statement & Financial Overview
Review Sumitomo Chemical Company, Limited's (SOMMF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $701.45B | $663.44B | $629.25B | $612.14B |
| Cost of Revenue | $513.75B | $475.83B | $450.91B | $440.31B |
| Gross Profit | $187.69B | $187.60B | $178.34B | $171.84B |
| Gross Profit Ratio | $0.27 | $0.28 | $0.28 | $0.28 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $154.72B | $146.07B | $149.06B | $151.24B |
| Operating Expenses | $154.72B | $163.42B | $149.06B | $160.34B |
| Total Costs & Expenses | $668.47B | $639.25B | $599.97B | $600.64B |
| Interest Income | -$17.11B | $22.47B | $0.00 | $40.16B |
| Interest Expense | $12.47B | $0.00 | $177.77B | $14.18B |
| Depreciation & Amortization | $32.17B | $32.62B | $33.24B | $33.57B |
| EBITDA | $74.66B | $77.09B | $72.71B | $102.58B |
| EBITDA Ratio | $0.11 | $0.12 | $0.12 | $0.17 |
| Operating Income | $32.98B | $24.18B | $29.28B | $28.85B |
| Operating Income Ratio | $0.05 | $0.04 | $0.05 | $0.05 |
| Other Income/Expenses (Net) | -$2.95B | $66.72B | -$167.59B | $25.98B |
| Income Before Tax | $30.03B | $90.90B | -$138.31B | $54.83B |
| Income Before Tax Ratio | $0.04 | $0.14 | -$0.22 | $0.09 |
| Income Tax Expense | $16.03B | $9.63B | -$13.85B | $3.60B |
| Net Income | $10.01B | $35.11B | -$30.91B | $24.38B |
| Net Income Ratio | $0.01 | $0.05 | -$0.05 | $0.04 |
| EPS | $6.12 | $21.46 | -$18.90 | $14.91 |
| Diluted EPS | $6.11 | $21.46 | -$18.90 | $14.90 |
| Weighted Avg Shares Outstanding | $1.64B | $1.64B | $1.64B | $1.64B |
| Weighted Avg Shares Outstanding (Diluted) | $1.64B | $1.64B | $1.64B | $1.64B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan